Inflammatory biomarkers and depression (Q28288750)

Plasma and platelet excitatory amino acids in psychiatric disorders.

Europe PubMed Central

title

Inflammatory biomarkers and depression (English)

0 references

0 references

0 references

1

Norbert Müller

0 references

author name string

Aye-Mu Myint

series ordinal

2

0 references

Markus J Schwarz

series ordinal

3

0 references

language of work or name

English

0 references

publication date

February 2011

0 references

published in

Neurotoxicity Research

0 references

volume

19

0 references

issue

2

0 references

page(s)

308-18

0 references

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9210-2

Episode-specific differential gene expression of peripheral blood mononuclear cells in rapid cycling supports novel treatment approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9210-2

Beneficial effects of the antiglutamatergic agent riluzole in a patient diagnosed with obsessive-compulsive disorder and major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9210-2

Beyond monoamines: glutamatergic function in mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9210-2

CSF corticotropin-releasing hormone in depressed patients and normal control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9210-2

Japanese encephalitis virus up-regulates expression of macrophage migration inhibitory factor (MIF) mRNA in the mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9210-2

CSF Prostaglandin Levels in Depressed and Schizophrenic Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12640-010-9210-2

Small-dose ketamine improves the postoperative state of depressed patients

21 January 2018

1 reference

12 December 2020

The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine

1 reference

12 December 2020

Inflammation and depression: is there a causal connection with dementia?

1 reference

12 December 2020

Relationship between cyclooxygenase-2 and nitric oxide synthase-2 in rat cortex after stress

1 reference

12 December 2020

Correlation between sICAM-1 and depressive symptoms during adjuvant treatment of melanoma with interferon-alpha.

1 reference

12 December 2020

The macrophage theory of depression

1 reference

12 December 2020

Exposure to excess glucocorticoids alters dendritic morphology of adult hippocampal pyramidal neurons

1 reference

12 December 2020

Cytokine production and treatment response in major depressive disorder

1 reference

12 December 2020

Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression.

1 reference

12 December 2020

Different immune patterns in melancholic and non-melancholic major depression

1 reference

12 December 2020

Acetylsalicylic acid accelerates the antidepressant effect of fluoxetine in the chronic escape deficit model of depression

1 reference

12 December 2020

Cerebrospinal fluid amines and higher-lethality suicide attempts in depressed inpatients

1 reference

12 December 2020

A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids

1 reference

12 December 2020

Indolamine 2,3-dioxygenase is expressed in the CNS and down-regulates autoimmune inflammation

1 reference

12 December 2020

MIF expression in the rat brain: implications for neuronal function

1 reference

12 December 2020

Brain IL-1-induced immunosuppression occurs through activation of both pituitary-adrenal axis and sympathetic nervous system by corticotropin-releasing factor

1 reference

12 December 2020

Modulation of neopterin formation and tryptophan degradation by Th1- and Th2-derived cytokines in human monocytic cells.

1 reference

12 December 2020

Inhibitors of cyclooxygenase-2, but not cyclooxygenase-1 provide structural and functional protection against quinolinic acid-induced neurodegeneration

1 reference

12 December 2020

Glutamatergic drugs for schizophrenia

1 reference

12 December 2020

Suicide attempts and impulse control disorder are related to low cerebrospinal fluid 5-HIAA in mentally disordered violent offenders.

1 reference

12 December 2020

Inflammatory markers in major depression and melancholia

1 reference

12 December 2020

Analysis of IL-1alpha, IL-1beta, and IL-1RA [correction of IL-RA] polymorphisms in dysthymia

1 reference

12 December 2020

Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination Survey

1 reference

12 December 2020

Dizocilpine (MK-801) increases not only dopamine but also serotonin and norepinephrine transmissions in the nucleus accumbens as measured by microdialysis in freely moving rats

1 reference

12 December 2020

Effect of rofecoxib on nociception and the serotonin system in the rat brain

1 reference

12 December 2020

Regulation of the kynurenine metabolic pathway by interferon-gamma in murine cloned macrophages and microglial cells.

1 reference

12 December 2020

Passage of cytokines across the blood-brain barrier

1 reference

12 December 2020

Shortened onset of action of antidepressants in major depression using acetylsalicylic acid augmentation: a pilot open-label study

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled study of preemptively administered intravenous parecoxib: effect on anxiety levels and procedural pain during epidural catheter placement for surgical operations or for chronic pain therapy

1 reference

12 December 2020

A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation

1 reference

12 December 2020

Lipopolysaccharide injected into the cerebral ventricle evokes fever through induction of cyclooxygenase-2 in brain endothelial cells.

1 reference

12 December 2020

Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial.

1 reference

12 December 2020

Increased level of salivary prostaglandins in patients with major depression

1 reference

12 December 2020

Association between depression and elevated C-reactive protein

1 reference

12 December 2020

Amantadine as augmentation therapy in the management of treatment-resistant depression

1 reference

12 December 2020

Major depressive disorder is associated with elevated monocyte counts

1 reference

12 December 2020

Exposure to acute stress induces brain interleukin-1beta protein in the rat.

1 reference

12 December 2020

Interleukin-1beta and tumor necrosis factor-alpha in children with major depressive disorder or dysthymia

1 reference

12 December 2020

C-reactive protein is associated with polymorphisms of the angiotensin-converting enzyme gene in major depressed patients

1 reference

12 December 2020

Stress-induced elevation of glucocorticoids increases microglia proliferation through NMDA receptor activation

1 reference

12 December 2020

An open-label trial of riluzole in patients with treatment-resistant major depression

1 reference

12 December 2020

Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial.

1 reference

12 December 2020

Possible association of interleukin-2 treatment with depression and suicide

1 reference

12 December 2020

Hypothesis: low serum cholesterol, suicide, and interleukin-2

1 reference

12 December 2020

Inhibition of T cell proliferation by macrophage tryptophan catabolism

1 reference

12 December 2020

Cytokine-induced sickness behavior: where do we stand?

1 reference

12 December 2020

Riluzole augmentation for treatment-resistant depression

1 reference

12 December 2020

Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1.

1 reference

12 December 2020

Cytokines and major depression

1 reference

12 December 2020

Decreased hippocampal NMDA, but not kainate or AMPA receptors in bipolar disorder

1 reference

12 December 2020

Endotoxin-induced changes in food consumption in healthy volunteers are associated with TNF-alpha and IL-6 secretion.

1 reference

12 December 2020

Depression and immunity: a meta-analytic review

1 reference

12 December 2020

Plasma levels of interleukin-1 beta and interleukin-6 in schizophrenia, other psychoses, and affective disorders

1 reference

12 December 2020

Interleukin-1beta (IL-1beta) gene and increased risk for the depressive symptom-dimension in schizophrenia spectrum disorders.

1 reference

12 December 2020

Depression, immunocompetence, and prostaglandins of the E series

1 reference

12 December 2020

The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder

1 reference

12 December 2020

Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression

1 reference

12 December 2020

Plasma CRP levels in premenopausal women with major depression: a 12-month controlled study

1 reference

12 December 2020

Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission

1 reference

12 December 2020

Prolonged effect of an anesthetic dose of ketamine on behavioral despair

1 reference

12 December 2020

Immune activation in non-treated suicidal major depression

1 reference

12 December 2020

Systemic PCP treatment elevates brain extracellular 5-HT: a microdialysis study in awake rats

1 reference

12 December 2020

Increased soluble interleukin-2 receptor concentrations in suicide attempters.

1 reference

12 December 2020

Corticosterone acutely prolonged N-methyl-d-aspartate receptor-mediated Ca2+ elevation in cultured rat hippocampal neurons

1 reference

12 December 2020

The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression

1 reference

12 December 2020

An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression

1 reference

12 December 2020

Depression, comorbidities and the TNF-α system

1 reference

12 December 2020

The immunological basis of glutamatergic disturbance in schizophrenia: towards an integrated view.

1 reference

12 December 2020

Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?

1 reference

12 December 2020

Urinary excretion of biopterin and neopterin in psychiatric disorders

1 reference

12 December 2020

Association of major depressive disorder with serum myeloperoxidase and other markers of inflammation: a twin study

1 reference

12 December 2020

Increased neopterin and interferon-gamma secretion and lower availability of L-tryptophan in major depression: further evidence for an immune response

1 reference

12 December 2020

Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study.

1 reference

12 December 2020

Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis.

1 reference

12 December 2020

Serum levels of excitatory amino acids, serine, glycine, histidine, threonine, taurine, alanine and arginine in treatment-resistant depression: modulation by treatment with antidepressants and prediction of clinical responsivity.

1 reference

12 December 2020

Cyloserine as an antidepressant agent

1 reference

12 December 2020

A mechanism for glucocorticoid toxicity in the hippocampus: increased neuronal vulnerability to metabolic insults.

1 reference

12 December 2020

Interleukin-6 and aging: blood levels and mononuclear cell production increase with advancing age and in vitro production is modifiable by dietary restriction

1 reference

12 December 2020

Physiological elevations of glucocorticoids potentiate glutamate accumulation in the hippocampus.

1 reference

12 December 2020

Role of interleukin-1 beta in impairment of contextual fear conditioning caused by social isolation

1 reference

12 December 2020

Effect of the COX-2 inhibitor celecoxib on behavioural and immune changes in an olfactory bulbectomised rat model of depression

1 reference

12 December 2020

Acute phase proteins in major depression

1 reference

12 December 2020

Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment

1 reference

12 December 2020

The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression

1 reference

12 December 2020

Immune markers in fibromyalgia: comparison with major depressed patients and normal volunteers.

1 reference

12 December 2020

Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones

1 reference

12 December 2020

Depression and cortisol responses to psychological stress: a meta-analysis

1 reference

12 December 2020

Cytokine-associated emotional and cognitive disturbances in humans

1 reference

12 December 2020

Possible association between -G308A tumour necrosis factor-alpha gene polymorphism and major depressive disorder in the Korean population.

1 reference

12 December 2020

Fluoxetine and amitriptyline inhibit nitric oxide, prostaglandin E2, and hyaluronic acid production in human synovial cells and synovial tissue cultures

1 reference

12 December 2020

Depressive symptomatology is associated with decreased interleukin-1 beta and increased interleukin-1 receptor antagonist levels in males.

1 reference

12 December 2020

Riluzole enhances glutamate uptake in rat astrocyte cultures

1 reference

12 December 2020

A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes.

1 reference

12 December 2020

Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia

1 reference

12 December 2020

Circulating levels of soluble intercellular adhesion molecule-1 (sICAM-1) independently predict depressive symptom severity after 12 months in heart failure patients.

1 reference

12 December 2020

Possible use of amantadine in depression

1 reference

12 December 2020

Raised plasma levels of tumor necrosis factor alpha in patients with depression: normalization during electroconvulsive therapy

1 reference

12 December 2020

Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system

1 reference

12 December 2020

Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression

1 reference

12 December 2020

Improved control of osteoarthritis pain and self-reported health status in non-responders to celecoxib switched to rofecoxib: results of PAVIA, an open-label post-marketing survey in Spain.

1 reference

12 December 2020

Plasma-soluble interleukin-2 and transferrin receptor in schizoprenia and major depression

1 reference

12 December 2020

The effect of NMDA antagonists on footshock-induced fighting behavior in chronically stressed rats

1 reference

12 December 2020

Inhibition of COX-2 reduces the age-dependent increase of hippocampal inflammatory markers, corticosterone secretion, and behavioral impairments in the rat.

1 reference

12 December 2020

Functional antagonists at the NMDA receptor complex exhibit antidepressant actions

1 reference

12 December 2020

Immune correlates of depression.

1 reference

12 December 2020

Effects of MK-801 and antidepressant drugs in the forced swimming test in rats

1 reference

12 December 2020

Elevated levels of kynurenic acid change the dopaminergic response to amphetamine: implications for schizophrenia

1 reference

12 December 2020

Blood levels of cytokines in elderly patients with major depressive disorder

1 reference

12 December 2020

Immunoregulators in the nervous system

1 reference

12 December 2020

The role of the hippocampus in the pathophysiology of major depression

1 reference

12 December 2020

Indicators of immune activation in major depression

1 reference

12 December 2020

Increased CD56+ natural killer cells and related cytokines in major depression

1 reference

12 December 2020

Glucocorticoids mediate the stress-induced extracellular accumulation of glutamate

1 reference

12 December 2020

Antidepressant effect of ketamine during ECT.

1 reference

12 December 2020

Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression

1 reference

12 December 2020

Sustained low-grade pro-inflammatory state in unmedicated, remitted women with major depressive disorder as evidenced by elevated serum levels of the acute phase proteins C-reactive protein and serum amyloid A

1 reference

12 December 2020

Inflammatory markers and cognitive function in middle-aged adults: the Whitehall II study

1 reference

12 December 2020

Acute-phase proteins and other systemic responses to inflammation

1 reference

12 December 2020

Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis

1 reference

12 December 2020

Investigations of the cellular immunity during depression and the free interval: evidence for an immune activation in affective psychosis

1 reference

12 December 2020

Inhibition of COX-2 by celecoxib enhances glucocorticoid receptor function

1 reference

12 December 2020

Alterations in the N-methyl-d-asparatate (NMDA) receptor complex in the frontal cortex of suicide victims

1 reference

12 December 2020

The role of IFN-gamma and TNF-alpha-responsive regulatory elements in the synergistic induction of indoleamine dioxygenase

1 reference

12 December 2020

Discovering endophenotypes for major depression

1 reference

12 December 2020

Immune and hormonal activity in adults suffering from depression

1 reference

12 December 2020

Increased serum glutamate in depressed patients

1 reference

12 December 2020

CSF 5-HIAA predicts suicide risk after attempted suicide

1 reference

12 December 2020

Plasma and platelet amino acid concentrations in patients affected by major depression and under fluvoxamine treatment

1 reference

12 December 2020

Macrophage migration inhibitory factor in the cerebrospinal fluid of patients with conventional and optic-spinal forms of multiple sclerosis and neuro-Behçet's disease

1 reference

12 December 2020

The NR1 subunit of the glutamate/NMDA receptor in the superior temporal cortex in schizophrenia and affective disorders

1 reference

12 December 2020

Neopterin measurement provides evidence of altered cell-mediated immunity in patients with depression, but not with schizophrenia

1 reference

12 December 2020

Cytokines: abnormalities in major depression and implications for pharmacological treatment.

1 reference

12 December 2020

The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments

1 reference

12 December 2020